乾景園林(603778.SH)擬清算註銷乾景寶生小貸公司
格隆匯8月20日丨乾景園林(603778.SH)公佈,公司於2019年8月19日召開第三屆董事會第三十次會議,審議通過了《關於清算註銷北京乾景寶生小額貸款有限責任公司的議案》,同意公司清算註銷北京乾景寶生小額貸款有限責任公司(“乾景寶生”)。
因公司2018年度每股收益為-0.01元,扣除非經常性損益後的每股收益-0.04元,絕對值均低於0.05元,按照《上海證券交易所股票上市規則》的相關規定,此次事項豁免提交股東大會審議。此次清算、註銷不會發生關聯交易事項,相關資產清算也不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.